
Sputnik V was developed by Russia’s Gamaleya National Research Institute of Epidemiology and Microbiology with the backing of Russia’s sovereign fund Russian Direct Investment Fund. It was registered by the Russian health ministry as the world’s first Covid-19 vaccine based on the human adenoviral vector platform.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3uQymsG
via
IFTTT
0 comments:
Post a Comment